Effect of inhaled interferon-β1a on SARS-CoV-2 diversity and evolution

By afschroeder • May 19, 2026

Edelstein GE, Sass TN, Deo R, Glover OT, Boucau J, Jaganathan P, Chew KW, Giganti MJ, Hughes MD, Moser C, Javan AC, Fletcher CV, McCarthy C, Wohl DA, Daar ES, Eron JJ, Currier JS, Singh U, Smith DM, Fischer W, Barczak AK, Choudhary MC, Li JZ; ACTIV-2/A5401 Study Team. Effect of inhaled interferon-β1a on SARS-CoV-2 diversity and evolution. Microbiol Spectr. 2026 May 18:e0054126. doi: 10.1128/spectrum.00541-26. Epub ahead of print. PMID: 42148571.

Tags: antiviral agents, Infectious Diseases, interferons, Publications, SARS-CoV-2, SARS-CoV-2 evolution, viral diversity

Field Performance and usability of a novel molecular point-of-care assay for Chlamydia trachomatis and Neisseria gonorrhoeae detection

Vasquez F, Okereke J, Vargas SK, Konda KA, Reyes-Diaz EM, Refat N, Unemo M, Klausner JD, Allan-Blitz LT. Field Performance and usability of a novel[...]

Yellow Fever Reemergence in Tolima, Colombia 2024-2025: An Eco-epidemiological Study

Judson SD, Stephan N, Machuca S, Henao-Martínez AF, Parra-Henao G, Vivas R, Alarcón-Robayo JF, Vera Soto MJ, Vargas H. Yellow Fever Reemergence in Tolima, Colombia[...]

Looking for Something Nobody Is Counting

Uslan DZ. Looking for Something Nobody Is Counting. Clin Infect Dis. 2026 Oct 10:ciag587. doi: 10.1093/cid/ciag587. Epub ahead of print. PMID: 42857899.